Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
$4.78
-9.3%
$5.92
$0.23
$14.11
$150.19M1.65700,896 shs538,849 shs
Electromed, Inc. stock logo
ELMD
Electromed
$24.77
+19.9%
$19.65
$13.74
$35.56
$207.72M0.3883,857 shs295,300 shs
LENSAR, Inc. stock logo
LNSR
LENSAR
$12.19
-3.2%
$12.86
$3.80
$17.31
$145.55M0.5127,598 shs60,595 shs
SurgePays, Inc. stock logo
SURG
SurgePays
$2.57
+3.2%
$2.86
$1.05
$3.47
$52.51M0.44718,819 shs80,371 shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
-0.57%+9.56%+10.02%-9.91%+1,077.65%
Electromed, Inc. stock logo
ELMD
Electromed
+2.28%+7.83%+9.78%+1.62%+36.37%
LENSAR, Inc. stock logo
LNSR
LENSAR
-0.55%+0.72%-3.52%-7.29%+176.70%
SurgePays, Inc. stock logo
SURG
SurgePays
0.00%+9.69%-15.31%-18.63%+33.16%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
2.41 of 5 stars
3.50.00.00.02.71.70.6
Electromed, Inc. stock logo
ELMD
Electromed
2.3178 of 5 stars
3.73.00.00.02.01.70.0
LENSAR, Inc. stock logo
LNSR
LENSAR
1.0446 of 5 stars
2.01.00.00.03.22.50.0
SurgePays, Inc. stock logo
SURG
SurgePays
3.0299 of 5 stars
3.55.00.00.01.61.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
3.00
Buy$10.00109.21% Upside
Electromed, Inc. stock logo
ELMD
Electromed
3.33
Buy$36.2546.35% Upside
LENSAR, Inc. stock logo
LNSR
LENSAR
2.00
Hold$15.0023.05% Upside
SurgePays, Inc. stock logo
SURG
SurgePays
3.00
Buy$9.00250.19% Upside

Current Analyst Ratings Breakdown

Latest SURG, ELMD, BSGM, and LNSR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/27/2025
Electromed, Inc. stock logo
ELMD
Electromed
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$36.00
8/27/2025
Electromed, Inc. stock logo
ELMD
Electromed
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$29.00 ➝ $35.00
8/27/2025
Electromed, Inc. stock logo
ELMD
Electromed
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$36.00
7/22/2025
Electromed, Inc. stock logo
ELMD
Electromed
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$29.00
7/21/2025
Electromed, Inc. stock logo
ELMD
Electromed
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/16/2025
SurgePays, Inc. stock logo
SURG
SurgePays
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.75 ➝ $9.00
6/6/2025
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$2.50 ➝ $10.00
(Data available from 8/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
$40K3,754.69N/AN/A($0.11) per share-43.45
Electromed, Inc. stock logo
ELMD
Electromed
$61.44M3.38$0.60 per share41.36$5.10 per share4.86
LENSAR, Inc. stock logo
LNSR
LENSAR
$53.49M2.72N/AN/A($1.93) per share-6.32
SurgePays, Inc. stock logo
SURG
SurgePays
$36.46M1.44N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
-$10.33MN/A0.00N/AN/AN/A-5,336.99%-90.03%11/13/2025 (Estimated)
Electromed, Inc. stock logo
ELMD
Electromed
$5.15M$0.7933.03N/A11.34%15.71%13.37%N/A
LENSAR, Inc. stock logo
LNSR
LENSAR
-$31.40M-$4.21N/AN/A-84.49%-737.30%-72.60%11/6/2025 (Estimated)
SurgePays, Inc. stock logo
SURG
SurgePays
-$45.73M-$2.49N/AN/AN/A-133.85%-333.87%-195.36%11/11/2025 (Estimated)

Latest SURG, ELMD, BSGM, and LNSR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/15/2025Q2 2025
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
-$0.04-$0.74-$0.70-$0.74N/AN/A
8/13/2025Q2 2025
SurgePays, Inc. stock logo
SURG
SurgePays
-$0.31-$0.36-$0.05-$0.36$16.14 million$11.52 million
8/7/2025Q2 2025
LENSAR, Inc. stock logo
LNSR
LENSAR
-$0.0750-$0.15-$0.0750-$0.15$16.55 million$11.36 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
N/AN/AN/AN/AN/A
Electromed, Inc. stock logo
ELMD
Electromed
N/AN/AN/AN/AN/A
LENSAR, Inc. stock logo
LNSR
LENSAR
N/AN/AN/AN/AN/A
SurgePays, Inc. stock logo
SURG
SurgePays
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
N/A
0.03
0.03
Electromed, Inc. stock logo
ELMD
Electromed
N/A
5.10
4.74
LENSAR, Inc. stock logo
LNSR
LENSAR
N/A
1.52
0.88
SurgePays, Inc. stock logo
SURG
SurgePays
101.87
1.11
0.84

Institutional Ownership

CompanyInstitutional Ownership
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
7.16%
Electromed, Inc. stock logo
ELMD
Electromed
40.82%
LENSAR, Inc. stock logo
LNSR
LENSAR
40.15%
SurgePays, Inc. stock logo
SURG
SurgePays
6.94%

Insider Ownership

CompanyInsider Ownership
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
24.80%
Electromed, Inc. stock logo
ELMD
Electromed
14.00%
LENSAR, Inc. stock logo
LNSR
LENSAR
66.00%
SurgePays, Inc. stock logo
SURG
SurgePays
30.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biosig Technologies, Inc. stock logo
BSGM
Biosig Technologies
5031.42 million23.63 millionNo Data
Electromed, Inc. stock logo
ELMD
Electromed
1608.39 million7.36 millionOptionable
LENSAR, Inc. stock logo
LNSR
LENSAR
11011.94 million4.06 millionOptionable
SurgePays, Inc. stock logo
SURG
SurgePays
4020.43 million14.20 millionOptionable

Recent News About These Companies

Phone-in-a-Box Prepaid Service Smartphones
SurgePays (NASDAQ:SURG) Cut to "Sell" at Wall Street Zen
SurgePays, Inc. (SURG) Q2 2025 Earnings Call Transcript
GPOPlus+ Shareholder Update

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Biosig Technologies stock logo

Biosig Technologies NASDAQ:BSGM

$4.78 -0.49 (-9.30%)
Closing price 04:00 PM Eastern
Extended Trading
$4.88 +0.10 (+2.09%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Electromed stock logo

Electromed NYSE:ELMD

$24.77 +4.11 (+19.89%)
Closing price 04:00 PM Eastern
Extended Trading
$24.71 -0.06 (-0.24%)
As of 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

LENSAR stock logo

LENSAR NASDAQ:LNSR

$12.19 -0.40 (-3.18%)
Closing price 04:00 PM Eastern
Extended Trading
$12.20 +0.01 (+0.08%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

SurgePays stock logo

SurgePays NASDAQ:SURG

$2.57 +0.08 (+3.21%)
Closing price 04:00 PM Eastern
Extended Trading
$2.60 +0.03 (+1.32%)
As of 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee.